< Back to companies

Replika

AI emotional support companion

San Francisco, California, USA

AI companion chatbot platform providing empathetic conversation with judgment-free interaction.

Share
Shareable draft
Hero image for Replika
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Get Involved in Replika

1 engagement

How We Help

Problem Statement

Individuals experience loneliness, mental well-being challenges, and a need for non-judgmental emotional support and personal growth.

Core Technology

Generative AI chatbot powered by natural language processing (NLP) and machine learning, utilizing a sophisticated neural network machine learning model and scripted dialogue content.

Key Differentiators

Emphasis on emotional understanding, serving as an empathetic listener, supportive and non-judgmental companion, personalized experience. Its newer offering, Tomo, combines an interactive 3D environment, generative AI guidance, and coaching from clinical specialists.

Clinical Focus

Emotional support, mental well-being, personal growth, and addressing loneliness. Some exercises are informed by CBT therapists.

Target Customers

Individuals seeking emotional support, mental well-being, and personal growth.

Product Stage

Mature

Company Info

Business Model
B2C Subscription
Founded
2015
Total Funding
Only accessible to MedStartr community members. Join now
Website
replika.com/

Categories

Behavioral Health Care

Disease Areas

Technologies

Conversational AILLMsMachine LearningNeural NetworksGenerative AINLP

Clinical & IP

🔬

Clinical Validation

One peer-reviewed study (Nature, 2023) on loneliness reduction in students. No FDA clearance. Mixed evidence: benefits for loneliness/anxiety offset by documented emotional dependency concerns.

Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Replika?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Replika

1 engagement

💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free